MedPath

Effect of heparin to prevent obstruction of the Hickman® catheter

Not Applicable
Recruiting
Conditions
This research will be performed on the Hickman® catheter inserted in the patients submitted to hematopoietic stem cell transplantation.Central venous catheters, hematopoietic stem cell transplantation.
E07.132.750.500
E04.936.225.687.500
Registration Number
RBR-3ht499
Lead Sponsor
Hospital de Clínicas Universidade Federal do Paraná
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Being hospitalized in the research unit; Have indication of implantation of Hickman® semi-implantable central venous catheter; Insertion of the Hickman® semi-implantable central venous catheter into the research unit or use of the first Hickman® semi-implantable central venous catheter in the research unit; First hospitalization for transplantation of stem cells in the bone marrow transplantation service in the complex of clinics of the Federal University of Paraná.

Exclusion Criteria

Being on anticoagulant by any route of administration; Being in fibrinolytic therapy; Present a history of allergy to heparin components; Bleeding during the period of data collection; Be refractory to platelet transfusion; Have had previous hospitalization in the research unit.

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath